CVS
HealthcareCVS Health Corporation
$76.12+0.05 (+0.07%)
Prev Close
$76.07
Open
$76.84
High
$77.17
Low
$76.11
Volume
2.82M
Market Cap
$96.78B
P/E
—
Div Yield
0.03%
Over the past 12 months, insider activity at CVS Health Corporation (CVS) has been dominated by selling, with 3 insider purchases totaling $105.9K and 15 insider sales totaling $258.55M. The most recent insider transaction was by Nelson Steven H (officer: EVP and President, Aetna), who purchased $1.3K worth of shares on Jan 27, 2026. CVS Health Corporation operates in the Healthcare sector, within the Medical - Healthcare Plans industry, with a market cap of $96.78B.
Buys (12M)
3
$105.9K
Sells (12M)
15
$258.55M
Net Activity
Net Seller
$258.44M
Active Insiders
13
last 12 mo
CVS Price Chart
CVS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026↗ | Nelson Steven H | officer: EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 24 |
| Jan 5, 2026↗ | Shah Prem S | EVP and Group President | Sell | 247 | $80.13 | $19.8K | 0 |
| Dec 2, 2025↗ | CAPOZZI HEIDI B | EVP and Chief People Officer | Sell | 9,470 | $80.36 | $761.0K | 0 |
| Dec 2, 2025↗ | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 6,575 | $80.36 | $528.4K | 0 |
| Dec 1, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 220 | $79.10 | $17.4K | 0 |
| Nov 30, 2025↗ | FARAH ROGER N | Director | Sell | 9,748 | $80.36 | $783.3K | 0 |
| Oct 14, 2025↗ | CAPOZZI HEIDI B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4.6K | 0 |
| Sep 2, 2025↗ | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 12,834 | $73.15 | $938.8K | 0 |
| Sep 2, 2025↗ | Shah Prem S | EVP and Group President | Sell | 6,995 | $73.15 | $511.7K | 0 |
| Aug 20, 2025↗ | Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532.6K | 0 |
| Jun 9, 2025↗ | SANSONE GUY P | Director | Buy | 1,570 | $63.70 | $100.0K | 0 |
| May 6, 2025↗ | ROBBINS LARRY | Director | Sell | 3,750,000 | $67.65 | $253.69M | 0 |
| Apr 3, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 2,266 | $67.98 | $154.0K | 0 |
| Apr 3, 2025↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 3,203 | $67.98 | $217.7K | 0 |
| Apr 3, 2025↗ | Joyner J. David | President and CEO | Sell | 1,847 | $67.98 | $125.6K | 0 |
| Apr 3, 2025↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 1,548 | $67.98 | $105.2K | 0 |
| Apr 3, 2025↗ | Mandadi Tilak | EVP, Chief Experience & Tech | Sell | 995 | $67.98 | $67.6K | 0 |
| Apr 3, 2025↗ | Shah Prem S | EVP and Group President | Sell | 1,308 | $67.98 | $88.9K | 0 |
| Mar 7, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 7,513 | $66.35 | $498.5K | 0 |
| Mar 3, 2025↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 5,318 | $65.72 | $349.5K | 0 |
| Mar 3, 2025↗ | Joyner J. David | President and CEO | Sell | 1,944 | $65.72 | $127.8K | 0 |
| Mar 3, 2025↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 5,604 | $65.72 | $368.3K | 0 |
| Feb 19, 2025↗ | Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2.00M | 0 |
| Jan 23, 2025↗ | Nelson Steven H | EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 0 |
| Nov 30, 2024↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 86 | $59.85 | $5.1K | 0 |
| Aug 31, 2024↗ | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,097 | $57.24 | $749.7K | 0 |
| May 2, 2024↗ | LUDWIG EDWARD J | Director | Buy | 1,000 | $53.88 | $53.9K | 0 |
| May 2, 2024↗ | Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500.3K | 0 |
| Apr 1, 2024↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 2,298 | $79.56 | $182.8K | 0 |
| Apr 1, 2024↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 3,004 | $79.56 | $239.0K | 0 |
| Apr 1, 2024↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 1,719 | $79.56 | $136.8K | 0 |
| Apr 1, 2024↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 7,630 | $79.56 | $607.0K | 0 |
| Apr 1, 2024↗ | Lynch Karen S | President and CEO | Sell | 61,953 | $79.56 | $4.93M | 0 |
| Apr 1, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 7,892 | $79.56 | $627.9K | 0 |
| Feb 28, 2024↗ | COWHEY THOMAS F. | SVP, Interim CFO | Sell | 5,641 | $75.19 | $424.1K | 0 |
| Feb 28, 2024↗ | Joyner J. David | EVP&President-PharmacyServices | Sell | 1,970 | $75.19 | $148.1K | 0 |
| Feb 28, 2024↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 6,210 | $75.19 | $466.9K | 0 |
| Feb 26, 2024↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 355 | $76.43 | $27.1K | 0 |
| Feb 26, 2024↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 6,698 | $76.43 | $511.9K | 0 |
| Feb 26, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 261 | $76.43 | $19.9K | 0 |
| Feb 16, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2.27M | 0 |
| Dec 14, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 122 | $68.48 | $8.4K | 0 |
| Nov 3, 2023↗ | LUDWIG EDWARD J | Director | Buy | 2,000 | $70.47 | $140.9K | 0 |
| Aug 31, 2023↗ | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,053 | $65.17 | $850.7K | 0 |
| Aug 31, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 3,508 | $65.17 | $228.6K | 0 |
| Aug 3, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.93 | $1.93M | 0 |
| May 3, 2023↗ | Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976.6K | 0 |
| Apr 1, 2023↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 1,854 | $74.31 | $137.8K | 0 |
| Apr 1, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,471 | $74.31 | $109.3K | 0 |
| Apr 1, 2023↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 3,856 | $74.31 | $286.5K | 0 |
| Apr 1, 2023↗ | Lynch Karen S | President and CEO | Sell | 93,677 | $74.31 | $6.96M | 0 |
| Apr 1, 2023↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 98,299 | $74.31 | $7.30M | 0 |
| Apr 1, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 3,221 | $74.31 | $239.4K | 0 |
| Feb 28, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 179 | $83.54 | $15.0K | 0 |
| Feb 27, 2023↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 438 | $85.16 | $37.3K | 0 |
| Feb 27, 2023↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 4,046 | $85.77 | $347.0K | 0 |
| Feb 27, 2023↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 12,304 | $85.77 | $1.06M | 0 |
| Feb 27, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 226 | $85.77 | $19.4K | 0 |
| Dec 31, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 292,856 | $93.19 | $27.29M | 0 |
| Dec 15, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 137,466 | $98.36 | $13.52M | 0 |
| Dec 1, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 153 | $101.65 | $15.6K | 0 |
| Nov 29, 2022↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 442 | $100.88 | $44.6K | 0 |
| Aug 3, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 9,546 | $100.00 | $954.6K | 0 |
| Aug 3, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 143,440 | $98.94 | $14.19M | 0 |
| Jun 28, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 138,654 | $95.00 | $13.17M | 0 |
| Apr 8, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 16,954 | $105.00 | $1.78M | 0 |
| Apr 4, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 61,300 | $100.12 | $6.14M | 0 |
| Apr 1, 2022↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 80,139 | $101.09 | $8.10M | 0 |
| Apr 1, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,637 | $101.09 | $670.9K | 0 |
| Apr 1, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 17,388 | $101.09 | $1.76M | 0 |
| Apr 1, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 38,129 | $101.09 | $3.85M | 0 |
| Apr 1, 2022↗ | Lynch Karen S | President and CEO | Sell | 116,940 | $101.09 | $11.82M | 0 |
| Apr 1, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 109,410 | $101.09 | $11.06M | 0 |
| Apr 1, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 22,478 | $101.09 | $2.27M | 0 |
| Mar 30, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 5,346 | $104.70 | $559.7K | 0 |
| Mar 17, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 4,624 | $106.65 | $493.1K | 0 |
| Mar 15, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 51,361 | $105.00 | $5.39M | 0 |
| Feb 28, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 436 | $103.65 | $45.2K | 0 |
| Feb 26, 2022↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 5,233 | $104.30 | $545.8K | 0 |
| Feb 26, 2022↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 12,609 | $104.30 | $1.32M | 0 |
| Feb 26, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 367 | $104.05 | $38.2K | 0 |
| Feb 10, 2022↗ | LUDWIG EDWARD J | Director | Buy | 1,000 | $105.90 | $105.9K | 0 |
| Feb 3, 2022↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 47,937 | $110.00 | $5.27M | 0 |
| Feb 1, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 21,386 | $106.50 | $2.28M | 0 |
| Jan 28, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,059 | $109.00 | $660.4K | 0 |
| Jan 27, 2022↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 68,482 | $107.50 | $7.36M | 0 |
| Dec 27, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 200 | $88.78 | $17.8K | 0 |
| Dec 1, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 68 | $88.78 | $6.0K | 0 |
| Nov 28, 2021↗ | Lynch Karen S | President and CEO | Sell | 14,121 | $91.52 | $1.29M | 0 |
| Nov 3, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 108,870 | $95.00 | $10.34M | 0 |
| Nov 1, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 28,159 | $90.00 | $2.53M | 0 |
| Oct 26, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 82,757 | $88.00 | $7.28M | 0 |
| Sep 2, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 2,625 | $87.00 | $228.4K | 0 |
| Aug 5, 2021↗ | LUDWIG EDWARD J | Director | Buy | 3,000 | $79.55 | $238.6K | 0 |
| Jun 28, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 2,781 | $83.67 | $232.7K | 0 |
| Jun 15, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 67,552 | $86.00 | $5.81M | 0 |
| Jun 7, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 37,594 | $86.60 | $3.26M | 0 |
| May 31, 2021↗ | MERLO LARRY J | Director | Sell | 634 | $86.44 | $54.8K | 0 |
| May 10, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 109,469 | $86.00 | $9.41M | 0 |
| May 7, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 9,477 | $84.00 | $796.1K | 0 |
| May 4, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 4,905 | $80.00 | $392.4K | 0 |
| Apr 21, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 103,423 | $77.00 | $7.96M | 0 |
| Apr 3, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 480 | $74.30 | $35.7K | 0 |
| Apr 3, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 1,705 | $74.30 | $126.7K | 0 |
| Mar 31, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 5,350 | $76.00 | $406.6K | 0 |
| Mar 29, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 62,943 | $76.15 | $4.79M | 0 |
| Mar 26, 2021↗ | MERLO LARRY J | Director | Sell | 270,650 | $74.73 | $20.23M | 0 |
| Mar 26, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 73,433 | $74.49 | $5.47M | 0 |
| Mar 19, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 49,211 | $74.15 | $3.65M | 0 |
| Mar 16, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 18,882 | $74.68 | $1.41M | 0 |
| Mar 2, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 2,413 | $68.94 | $166.4K | 0 |
| Feb 28, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,129 | $68.13 | $76.9K | 0 |
| Feb 1, 2021↗ | Bisaccia Lisa | Former EVP & Chief HR Officer | Sell | 36,310 | $74.30 | $2.70M | 0 |
| Feb 1, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 40,777 | $74.30 | $3.03M | 0 |
| Feb 1, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 44,478 | $74.30 | $3.30M | 0 |
| Feb 1, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,749 | $74.30 | $501.5K | 0 |
| Feb 1, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 10,584 | $74.30 | $786.4K | 0 |
| Feb 1, 2021↗ | Lynch Karen S | EVP and President, Aetna | Sell | 43,211 | $74.30 | $3.21M | 0 |
| Feb 1, 2021↗ | MERLO LARRY J | Director | Sell | 81,700 | $74.30 | $6.07M | 0 |
| Feb 1, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 63,445 | $74.30 | $4.71M | 0 |
| Feb 1, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 79,714 | $74.30 | $5.92M | 0 |
CVS Insider Buying Activity
The following table shows recent insider purchases of CVS Health Corporation (CVS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026↗ | Nelson Steven H | officer: EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 24 |
| Oct 14, 2025↗ | CAPOZZI HEIDI B | EVP and Chief People Officer | Buy | 80 | $57.36 | $4.6K | 0 |
| Jun 9, 2025↗ | SANSONE GUY P | Director | Buy | 1,570 | $63.70 | $100.0K | 0 |
| Feb 19, 2025↗ | Mahoney Michael F | Director | Buy | 30,000 | $66.70 | $2.00M | 0 |
| Jan 23, 2025↗ | Nelson Steven H | EVP and President, Aetna | Buy | 24 | $53.70 | $1.3K | 0 |
| May 2, 2024↗ | LUDWIG EDWARD J | Director | Buy | 1,000 | $53.88 | $53.9K | 0 |
| May 2, 2024↗ | Mahoney Michael F | Director | Buy | 9,181 | $54.49 | $500.3K | 0 |
| Nov 3, 2023↗ | LUDWIG EDWARD J | Director | Buy | 2,000 | $70.47 | $140.9K | 0 |
| May 3, 2023↗ | Lynch Karen S | President and CEO | Buy | 14,000 | $69.75 | $976.6K | 0 |
| Feb 10, 2022↗ | LUDWIG EDWARD J | Director | Buy | 1,000 | $105.90 | $105.9K | 0 |
| Aug 5, 2021↗ | LUDWIG EDWARD J | Director | Buy | 3,000 | $79.55 | $238.6K | 0 |
CVS Insider Selling Activity
The following table shows recent insider sales of CVS Health Corporation (CVS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026↗ | Shah Prem S | EVP and Group President | Sell | 247 | $80.13 | $19.8K | 0 |
| Dec 2, 2025↗ | CAPOZZI HEIDI B | EVP and Chief People Officer | Sell | 9,470 | $80.36 | $761.0K | 0 |
| Dec 2, 2025↗ | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 6,575 | $80.36 | $528.4K | 0 |
| Dec 1, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 220 | $79.10 | $17.4K | 0 |
| Nov 30, 2025↗ | FARAH ROGER N | Director | Sell | 9,748 | $80.36 | $783.3K | 0 |
| Sep 2, 2025↗ | Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 12,834 | $73.15 | $938.8K | 0 |
| Sep 2, 2025↗ | Shah Prem S | EVP and Group President | Sell | 6,995 | $73.15 | $511.7K | 0 |
| Aug 20, 2025↗ | Finucane Anne A. | Director | Sell | 7,500 | $71.02 | $532.6K | 0 |
| May 6, 2025↗ | ROBBINS LARRY | Director | Sell | 3,750,000 | $67.65 | $253.69M | 0 |
| Apr 3, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 2,266 | $67.98 | $154.0K | 0 |
| Apr 3, 2025↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 3,203 | $67.98 | $217.7K | 0 |
| Apr 3, 2025↗ | Joyner J. David | President and CEO | Sell | 1,847 | $67.98 | $125.6K | 0 |
| Apr 3, 2025↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 1,548 | $67.98 | $105.2K | 0 |
| Apr 3, 2025↗ | Mandadi Tilak | EVP, Chief Experience & Tech | Sell | 995 | $67.98 | $67.6K | 0 |
| Apr 3, 2025↗ | Shah Prem S | EVP and Group President | Sell | 1,308 | $67.98 | $88.9K | 0 |
| Mar 7, 2025↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 7,513 | $66.35 | $498.5K | 0 |
| Mar 3, 2025↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 5,318 | $65.72 | $349.5K | 0 |
| Mar 3, 2025↗ | Joyner J. David | President and CEO | Sell | 1,944 | $65.72 | $127.8K | 0 |
| Mar 3, 2025↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 5,604 | $65.72 | $368.3K | 0 |
| Nov 30, 2024↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 86 | $59.85 | $5.1K | 0 |
| Aug 31, 2024↗ | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,097 | $57.24 | $749.7K | 0 |
| Apr 1, 2024↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 2,298 | $79.56 | $182.8K | 0 |
| Apr 1, 2024↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 3,004 | $79.56 | $239.0K | 0 |
| Apr 1, 2024↗ | COWHEY THOMAS F. | EVP and CFO | Sell | 1,719 | $79.56 | $136.8K | 0 |
| Apr 1, 2024↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 7,630 | $79.56 | $607.0K | 0 |
| Apr 1, 2024↗ | Lynch Karen S | President and CEO | Sell | 61,953 | $79.56 | $4.93M | 0 |
| Apr 1, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 7,892 | $79.56 | $627.9K | 0 |
| Feb 28, 2024↗ | COWHEY THOMAS F. | SVP, Interim CFO | Sell | 5,641 | $75.19 | $424.1K | 0 |
| Feb 28, 2024↗ | Joyner J. David | EVP&President-PharmacyServices | Sell | 1,970 | $75.19 | $148.1K | 0 |
| Feb 28, 2024↗ | Khichi Samrat S. | EVP, CPO and General Counsel | Sell | 6,210 | $75.19 | $466.9K | 0 |
| Feb 26, 2024↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 355 | $76.43 | $27.1K | 0 |
| Feb 26, 2024↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 6,698 | $76.43 | $511.9K | 0 |
| Feb 26, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 261 | $76.43 | $19.9K | 0 |
| Feb 16, 2024↗ | Shah Prem S | EVP and Pres-Pharm, Consumer W | Sell | 29,473 | $76.95 | $2.27M | 0 |
| Dec 14, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 122 | $68.48 | $8.4K | 0 |
| Aug 31, 2023↗ | Mandadi Tilak | EVP, Chief Technology Officer | Sell | 13,053 | $65.17 | $850.7K | 0 |
| Aug 31, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 3,508 | $65.17 | $228.6K | 0 |
| Aug 3, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 25,759 | $74.93 | $1.93M | 0 |
| Apr 1, 2023↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 1,854 | $74.31 | $137.8K | 0 |
| Apr 1, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,471 | $74.31 | $109.3K | 0 |
| Apr 1, 2023↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 3,856 | $74.31 | $286.5K | 0 |
| Apr 1, 2023↗ | Lynch Karen S | President and CEO | Sell | 93,677 | $74.31 | $6.96M | 0 |
| Apr 1, 2023↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 98,299 | $74.31 | $7.30M | 0 |
| Apr 1, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 3,221 | $74.31 | $239.4K | 0 |
| Feb 28, 2023↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 179 | $83.54 | $15.0K | 0 |
| Feb 27, 2023↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 438 | $85.16 | $37.3K | 0 |
| Feb 27, 2023↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 4,046 | $85.77 | $347.0K | 0 |
| Feb 27, 2023↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 12,304 | $85.77 | $1.06M | 0 |
| Feb 27, 2023↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 226 | $85.77 | $19.4K | 0 |
| Dec 31, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 292,856 | $93.19 | $27.29M | 0 |
| Dec 15, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 137,466 | $98.36 | $13.52M | 0 |
| Dec 1, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 153 | $101.65 | $15.6K | 0 |
| Nov 29, 2022↗ | Chaguturu Sreekanth K | EVP and Chief Medical Officer | Sell | 442 | $100.88 | $44.6K | 0 |
| Aug 3, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 9,546 | $100.00 | $954.6K | 0 |
| Aug 3, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 143,440 | $98.94 | $14.19M | 0 |
| Jun 28, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 138,654 | $95.00 | $13.17M | 0 |
| Apr 8, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 16,954 | $105.00 | $1.78M | 0 |
| Apr 4, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 61,300 | $100.12 | $6.14M | 0 |
| Apr 1, 2022↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 80,139 | $101.09 | $8.10M | 0 |
| Apr 1, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,637 | $101.09 | $670.9K | 0 |
| Apr 1, 2022↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 17,388 | $101.09 | $1.76M | 0 |
| Apr 1, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 38,129 | $101.09 | $3.85M | 0 |
| Apr 1, 2022↗ | Lynch Karen S | President and CEO | Sell | 116,940 | $101.09 | $11.82M | 0 |
| Apr 1, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 109,410 | $101.09 | $11.06M | 0 |
| Apr 1, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 22,478 | $101.09 | $2.27M | 0 |
| Mar 30, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 5,346 | $104.70 | $559.7K | 0 |
| Mar 17, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 4,624 | $106.65 | $493.1K | 0 |
| Mar 15, 2022↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 51,361 | $105.00 | $5.39M | 0 |
| Feb 28, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 436 | $103.65 | $45.2K | 0 |
| Feb 26, 2022↗ | Havanec Laurie P. | EVP and Chief People Officer | Sell | 5,233 | $104.30 | $545.8K | 0 |
| Feb 26, 2022↗ | PELUSO MICHELLE A | EVP and Co-President of Retail | Sell | 12,609 | $104.30 | $1.32M | 0 |
| Feb 26, 2022↗ | Shah Prem S | EVP and Co-President of Retail | Sell | 367 | $104.05 | $38.2K | 0 |
| Feb 3, 2022↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 47,937 | $110.00 | $5.27M | 0 |
| Feb 1, 2022↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 21,386 | $106.50 | $2.28M | 0 |
| Jan 28, 2022↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,059 | $109.00 | $660.4K | 0 |
| Jan 27, 2022↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 68,482 | $107.50 | $7.36M | 0 |
| Dec 27, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 200 | $88.78 | $17.8K | 0 |
| Dec 1, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 68 | $88.78 | $6.0K | 0 |
| Nov 28, 2021↗ | Lynch Karen S | President and CEO | Sell | 14,121 | $91.52 | $1.29M | 0 |
| Nov 3, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 108,870 | $95.00 | $10.34M | 0 |
| Nov 1, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 28,159 | $90.00 | $2.53M | 0 |
| Oct 26, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 82,757 | $88.00 | $7.28M | 0 |
| Sep 2, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 2,625 | $87.00 | $228.4K | 0 |
| Jun 28, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 2,781 | $83.67 | $232.7K | 0 |
| Jun 15, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 67,552 | $86.00 | $5.81M | 0 |
| Jun 7, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 37,594 | $86.60 | $3.26M | 0 |
| May 31, 2021↗ | MERLO LARRY J | Director | Sell | 634 | $86.44 | $54.8K | 0 |
| May 10, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 109,469 | $86.00 | $9.41M | 0 |
| May 7, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 9,477 | $84.00 | $796.1K | 0 |
| May 4, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 4,905 | $80.00 | $392.4K | 0 |
| Apr 21, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 103,423 | $77.00 | $7.96M | 0 |
| Apr 3, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 480 | $74.30 | $35.7K | 0 |
| Apr 3, 2021↗ | Lotvin Alan | EVP&President-PharmacyServices | Sell | 1,705 | $74.30 | $126.7K | 0 |
| Mar 31, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 5,350 | $76.00 | $406.6K | 0 |
| Mar 29, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 62,943 | $76.15 | $4.79M | 0 |
| Mar 26, 2021↗ | MERLO LARRY J | Director | Sell | 270,650 | $74.73 | $20.23M | 0 |
| Mar 26, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 73,433 | $74.49 | $5.47M | 0 |
| Mar 19, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 49,211 | $74.15 | $3.65M | 0 |
| Mar 16, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 18,882 | $74.68 | $1.41M | 0 |
| Mar 2, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 2,413 | $68.94 | $166.4K | 0 |
| Feb 28, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 1,129 | $68.13 | $76.9K | 0 |
| Feb 1, 2021↗ | Bisaccia Lisa | Former EVP & Chief HR Officer | Sell | 36,310 | $74.30 | $2.70M | 0 |
| Feb 1, 2021↗ | Boratto Eva C | EVP & CFO | Sell | 40,777 | $74.30 | $3.03M | 0 |
| Feb 1, 2021↗ | Brennan Troyen A | EVP and Chief Medical Officer | Sell | 44,478 | $74.30 | $3.30M | 0 |
| Feb 1, 2021↗ | Clark James David | SVP, Cont & Chief Acct Officer | Sell | 6,749 | $74.30 | $501.5K | 0 |
| Feb 1, 2021↗ | Finke Daniel P | EVP/Pres, Health Care Benefits | Sell | 10,584 | $74.30 | $786.4K | 0 |
| Feb 1, 2021↗ | Lynch Karen S | EVP and President, Aetna | Sell | 43,211 | $74.30 | $3.21M | 0 |
| Feb 1, 2021↗ | MERLO LARRY J | Director | Sell | 81,700 | $74.30 | $6.07M | 0 |
| Feb 1, 2021↗ | Moriarty Thomas M | EVP & General Counsel | Sell | 63,445 | $74.30 | $4.71M | 0 |
| Feb 1, 2021↗ | Roberts Jonathan C | EVP & Chief Operating Officer | Sell | 79,714 | $74.30 | $5.92M | 0 |
CVS Insiders
Similar Stocks to CVS
UNH
UnitedHealth Group Incorporated
$281.12+1.48%
$251.47B
CI
Cigna Corporation
$267.36+0.55%
$71.02B
ELV
Elevance Health Inc.
$290.36+0.86%
$63.54B
HUM
Humana Inc.
$165.53+1.14%
$21.12B
CNC
Centene Corporation
$34.41-0.46%
$20.67B
MOH
Molina Healthcare, Inc.
$149.63+0.30%
$7.48B
ALHC
Alignment Healthcare, Inc.
$16.94-1.05%
$3.68B
OSCR
Oscar Health, Inc.
$13.10+0.73%
$3.61B